BenzingaAugust 20, 2026 at 4:35 AM NY15 days ago
Why Is Tempus AI Stock Gaining Thursday?
Tempus AI (TEM) trades higher after positive Phase 3 mRNA cancer trial results spotlight its $1.5B acquisition of Personalis.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
Which dow jones stocks are moving on Friday?
ChartMill4 hours ago
Exploring the top movers within the S&P500 index during today's session.
ChartMill4 hours ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo4 hours ago
Sector Update: Financial
Yahoo5 hours ago
Should You Buy, Sell or Hold PVH Stock Post Q2 Earnings?
Yahoo6 hours ago